ConductScience.org, home

Paper40057791

Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.

Xie X and 4 others. Mol Cancer, 2025. Cited by 18 papers, by iCite.

Cite this record

ConductScience Library. Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications. Papers, record 40057791. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40057791

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bridging epigenomics and tumor immunometabolism: molecular mechanisms and therapeutic implications.
PubMed
Journal
Mol Cancer
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
18
iCite
Relative citation ratio, by iCite
4.4, provisional
iCite
Revised in PubMed
2026-11-04
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xie XXiaowen
2Liu WWeici
3Yuan ZZhiyuan
4Chen HHanqing
5Mao WWenjun

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeoplasmsMajor topic
EpigenomicsMajor topic
Epigenesis, GeneticMajor topic
Humans
Tumor Microenvironment
Animals
Immunotherapy
DNA Methylation
Gene Expression Regulation, Neoplastic

Source PubMed

Download CSV of topics

References209

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137757492Reprogramming the lipid metabolism of dendritic cells in tumor immunomodulation and immunotherapy.Biomed Pharmacother2023https://conductscience.org/library/papers/37757492PubMed
233546704The cancer metabolic reprogramming and immune response.Mol Cancer2021https://conductscience.org/library/papers/33546704PubMed
335340204Histone Methylation and Oxidative Stress in Cardiovascular Diseases.Oxid Med Cell Longev2022https://conductscience.org/library/papers/35340204PubMed
435316657The glucose transporter GLUT3 controls T helper 17 cell responses through glycolytic-epigenetic reprogramming.Cell Metab2022https://conductscience.org/library/papers/35316657PubMed
531475443Functions and mechanisms of lysine crotonylation.J Cell Mol Med2019https://conductscience.org/library/papers/31475443PubMed
635836809Histone acetyltransferases CBP/p300 in tumorigenesis and CBP/p300 inhibitors as promising novel anticancer agents.Theranostics2022https://conductscience.org/library/papers/35836809PubMed
735292092LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond.J Exp Clin Cancer Res2022https://conductscience.org/library/papers/35292092PubMed
836323249Metabolic regulation by p53 prevents R-loop-associated genomic instability.Cell Rep2022https://conductscience.org/library/papers/36323249PubMed
937801083BCAT2 promotes melanoma progression by activating lipogenesis via the epigenetic regulation of FASN and ACLY expressions.Cell Mol Life Sci2023https://conductscience.org/library/papers/37801083PubMed
1033953707Targeting SLC1A5 and SLC3A2/SLC7A5 as a Potential Strategy to Strengthen Anti-Tumor Immunity in the Tumor Microenvironment.Front Immunol2021https://conductscience.org/library/papers/33953707PubMed
1133581341Profiling Chromatin Accessibility at Single-cell Resolution.Genomics Proteomics Bioinformatics2021https://conductscience.org/library/papers/33581341PubMed
1238829740The histone deacetylase HDAC1 controls dendritic cell development and anti-tumor immunity.Cell Rep2024https://conductscience.org/library/papers/38829740PubMed
1331097476HDAC3 Deficiency Promotes Liver Cancer through a Defect in H3K9ac/H3K9me3 Transition.Cancer Res2019https://conductscience.org/library/papers/31097476PubMed
1435389425Metaboloepigenetics in cancer, immunity, and cardiovascular disease.Cardiovasc Res2023https://conductscience.org/library/papers/35389425PubMed
1532795401Integrated Metabolic and Epigenomic Reprograming by H3K27M Mutations in Diffuse Intrinsic Pontine Gliomas.Cancer Cell2020https://conductscience.org/library/papers/32795401PubMed
1630293904Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.Eur Urol2019https://conductscience.org/library/papers/30293904PubMed
1734330764Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies.J Immunother Cancer2021https://conductscience.org/library/papers/34330764PubMed
1831830561ATP citrate lyase: A central metabolic enzyme in cancer.Cancer Lett2020https://conductscience.org/library/papers/31830561PubMed
1933301708Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.Cell2020https://conductscience.org/library/papers/33301708PubMed
2039251875Spatial single-cell isotope tracing reveals heterogeneity of de novo fatty acid synthesis in cancer.Nat Metab2024https://conductscience.org/library/papers/39251875PubMed

See all 209 referencesDownload CSV of references

Cited by18

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.

PMIDTitleJournalYearIn PapersSource
42903418Molecular mechanisms and therapeutic strategies of immunotherapy resistance in esophageal cancer.Front Immunol2026https://conductscience.org/library/papers/42903418PubMed
42882485The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy.Cells2026https://conductscience.org/library/papers/42882485PubMed
42724854Combined multi-omics profiling and machine learning analysis reveals that Bregs and RPS2 promote bone metastasis in nasopharyngeal carcinoma.Transl Cancer Res2026https://conductscience.org/library/papers/42724854PubMed
42405329Tumor suppressor network dysregulation in neuroblastoma: molecular mechanisms and precision therapeutic opportunities.Front Cell Dev Biol2026https://conductscience.org/library/papers/42405329PubMed
42393287Histone lactylation-driven IGF2BP3 promotes intrahepatic cholangiocarcinoma progression via SPP1/CD44-dependent macrophage polarization.Oncogene2026https://conductscience.org/library/papers/42393287PubMed
42298579The nutrigenomic-epigenetic axis in cancer: from dietary bioactives to precision oncology.Nutr Metab (Lond)2026https://conductscience.org/library/papers/42298579PubMed
42222599Tumor ecosystem subtyping of breast cancer based on somatic mutations and network propagation reveals distinct prognostic and genomic landscapes.Front Genet2026https://conductscience.org/library/papers/42222599PubMed
42103495Bioengineered systems to exploit tumor microenvironment metabolism.Trends Cancer2026https://conductscience.org/library/papers/42103495PubMed
42100377The multistep progression of areca nut-induced oral cancer: a mechanistic roadmap from pathogenesis to precision therapy.Life Med2026https://conductscience.org/library/papers/42100377PubMed
42043678The crosstalk between epigenetics and metabolism in the malignant cell.Discov Oncol2026https://conductscience.org/library/papers/42043678PubMed
41977178Conserved Pathways, Divergent Outcomes: A Cross-Species Genomic Perspective on the Cancer-Neurodegeneration Paradox.Int J Mol Sci2026https://conductscience.org/library/papers/41977178PubMed
41814059Artificial intelligence-assisted spatial omics-based biomimetic nanoplatform for intelligent and precise intervention in the immunosuppressive core region of ovarian cancer.NPJ Precis Oncol2026https://conductscience.org/library/papers/41814059PubMed
41663693Hepatic stellate cell derived lipid droplets drive protumoral M2 macrophage polarization in hepatocellular carcinoma.Discov Oncol2026https://conductscience.org/library/papers/41663693PubMed
41311372Emerging hallmarks and the rise of complexities and heterogeneity of tumor.Biochem Biophys Rep2025https://conductscience.org/library/papers/41311372PubMed
41036475Delving Into the Dialogue between Epigenetic Modifications and Immunometabolism in Cancer.Adv Genet (Hoboken)2025https://conductscience.org/library/papers/41036475PubMed
40938975Metabolism-driven posttranslational modifications and immune regulation: Emerging targets for immunotherapy.Sci Adv2025https://conductscience.org/library/papers/40938975PubMed
40808802Substituted 1,4-naphthoquinones for potential anticancer therapeutics: In vitro cytotoxic effects and QSAR-guided design of new analogs.Comput Struct Biotechnol J2025https://conductscience.org/library/papers/40808802PubMed
40358164Epigenetic Control of Alveolar Macrophages: Impact on Lung Health and Disease.Cells2025https://conductscience.org/library/papers/40358164PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/40057791

GET https://conductscience.org/api/papers/v1/40057791/references?page=2